Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study is for individuals with lupus who have developed complications in their kidneys,
or lupus nephritis. The study will determine whether adding the experimental medication
abatacept to standard cyclophosphamide therapy is more effective in improving lupus nephritis
than standard cyclophosphamide therapy by itself.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)